The mitochondrial permeability transition pore is an inducer of cell death. During the reperfusion phase after cerebral ischemia, calcium accumulates in mitochondria, and a burst of free radical formation occurs, conditions that fa vor the activation of the mitochondrial permeability transition pore. Here the authors demonstrate that a blocker of the mito chondrial permeability transition pore, the nonimmunosup pressive cyclosporin A analogue N-methyl-Val-4-cyclosporin The importance of mitochondrial function and dys function in health and disease is under intense investiga tions (Brenner et al., 1998; Halestrap et al., 1998). Not only do mitochondria generate ATP needed to maintain the function of ion pumps and secure cell homeostasis, they also play an active role in physiologic cellular signal transduction and in pathophysiologic events (Cai et al., 1998; Ichas and Mazat, 1998). The focus of this interest in mitochondrial pathophysiology is the formation of a tightly regulated pore in the mitochondrial inner mem brane, the mitochondrial permeability transition (MPT) pore, under circumstances of oxidative stress and high calcium content (Hunter and Haworth, 1979b). The ac-Abbreviations: CsA, cyclosporin A; MCAO, middle cerebral artery occlusion; MeVaICsA, N-methyl-Val-4-cyclosporin A; MPT, mito chondrial permeability transition.
tivation of the MPT pore disrupts the permeability bar rier of the inner mitochondrial membrane, causing un coupling of oxidative phosphorylation, osmotic swelling, and rupture of the outer membrane. The concomitant release of mitochondrial proteins (Liu et aI., 1996) may then activate the caspase cascade, in turn activating en donuc1eases with subsequent irreversible DNA damage and cell death (Thornberry and Lazebnik, 1998) . It has been speculated that the extent of open MPT pores in the mitochondrial population of a cell will decide not only whether the cell will live or die, but whether the cell will die acutely from necrosis (-ATP) or suffer a delayed apoptotic death (+ATP) (Qian et aI., 1997) .
If the MPT pore is a critical factor in the development of ischemia-reperfusion damage, blockade of the MPT pore would be expected to protect from damage. Accord ingly, the immunosuppressive compound cyc1osporin A, a potent inhibitor of the MPT pore (Crompton et aI., 1988) , protects from excitotoxic cell death in vitro (Schinder et aI., 1996) and from ischemia-reperfusion damage in the isolated heart (Griffiths and Halestrap, 1993) and liver (Travis et aI., 1998) . Furthermore, its nonimmunosuppressive analogue and MPT pore blocker N-methyl-Val-4-cyc1osporin A (MeVaICsA) prevents apoptosis (Zamzami et aI., 1996) and protects cells from metabolic inhibition (Seaton et aI., 1998) . In the brain, cyclosporin A (CsA) and its analogues poorly penetrate the blood-brain barrier, but CsA has been reported to reduce damage caused by transient occlusion of the middle cerebral artery (MCAO) in at least two studies preceding the present one (Butcher et aI., 1997; Shiga et aI., 1992) . The mechanism whereby CsA is protective in ischemia-reperfusion damage is however equivocal. Cy closporin A may act by blocking the MPT, but may also inhibit calcineurin and therefore act as an immunosup pressant and an inhibitor of nitric oxide synthase (Daw son et aI., 1993; Liu et aI., 199 1) . In contrast, the CsA analogue MeValCsA has an MPT pore blocking property but does not inhibit calcineurin (Liu et a!., 1992) , making it a tool to assess the importance of MPT in pathogenic processes.
In this study, we present novel data on the neuropro tective effect of CsA, but also and more importantly, on the neuroprotective effect of its nonimmunosuppressive analogue MeValCsA in a filament model of transient focal ischemia, supporting the hypothesis of MPT pore involvement in brain ischemia-reperfusion damage.
MATERIALS AND METHODS
All animal experiments were approved by the ethical com mittee at the University of Lund.
Transient MCAO of the rats were performed as described previously (Memezawa et a!., 1992) and is summarized below.
Male Wi star rats (Mollegaard's Breeding Center, Copenhagen), weighing 310 to 350 g, were fasted overnight with free access to water. Anesthesia was induced by inhalation of 3% halo thane in N20:02 (70%:30%) and maintained at 1.5% during surgery. The tail artery was cannulated for blood sampling and blood pressure monitoring. Blood pressure, Pa02, Paco2, pH, and blood glucose level were measured, and 0.1 mL of heparin (300 units x mL -I ) was administered through the tail artery just before induction of ischemia. A surgical midline incision was made to expose the right common, internal, and external carotid arteries. The external carotid artery was ligated. The common carotid artery was occluded by a ligature, and the internal ca rotid artery was temporarily occluded by a microvascular clip.
A small incision was made in the common carotid artery, and a filament with a distal cylinder of silicon rubber (diameter 0. 28 mm), was inserted into the internal carotid artery through the common carotid artery. The filament was further advanced 19 mm to occlude the origin of the MCA. When the MCAO had been performed, animals were extubated and allowed to wake up and resume spontaneous breathing. While mask breathing halothane in N20:02, the filament was withdrawn after 2 hours to allow recirculation. During surgery, a thermistor probe was inserted into the rectum to monitor core temperature, which was maintained at 37°C. After surgery, the animals were cooled by an air cooling system to avoid hyperthermia (Zhao et a!., 1994) . Cooling was instituted at 30 minutes of ischemia and temperature did not exceed 38.9°C. Cooling was discontinued at 2 hours of reperfusion. Only rats that consistently circled toward the nonoccluded side (grade 3) during 2 hours of MCAO were included in this study, according to the neuro-logical examination grading system described by Bederson et a!. (1986b) .
Drug administration and experimental groups
Three experimental groups were studied: vehicle-treated group (n = 10), cyclosporin A-treated group (n = 6), and MeValCsA treated group (n = 5). Cyclosporin A (10 mglkg) or MeValCsA (10 mg/kg) were administered intraperitoneally immediately after recirculation, and after 24 hours of recircu lation. Stock solutions of CsA or MeValCsA were made up by dissolving 2.5 g of the substances in 32.5 g Cremophore (Sigma, St Louis, MO, U.S.A. ), and adding ethanol to a volume of 50 mL. Of this stock solution, 5 mL was then added to 20 mL saline, generating an injectable solution with a final con centration of 10 mg/mL. The same solution was used as ve hicle, omitting active substances.
Evaluation of infarct volume with TTC staining
At 48 hours of recovery following MCAO, the rats were anesthetized by inhalation of 3.0% halothane and killed by decapitation. The brain was quickly removed and chilled in ice-cold saline for 10 minutes. Twelve coronal slices were cut (1 mm thick), beginning I mm posterior to the anterior pole, and the slices were immersed in a saline solution containing 1. 0% 2,3,5-triphenyltetrazolium chloride (TTC)(Sigma) at 37°C for 30 minutes (Bederson et a!., 1986a) , and fixed by immersion in 4.0% phosphate-buffered formalin solution. Each brain slice was photographed with black and white film, and the unstained area in each photograph was quantified from the developed film, using a CCD video camera and a video image analyzing system (NIH image, version 1.55). The infarct area in the cortex and the striatum was assessed as the percentage of the total area of the contralateral hemisphere (Bederson et a!., 1986a) . The total infarct volume was determined by summing up the infarct areas of the 12 slices.
Measurements of mitochondrial pore opening
Brain mitochondria from striatum and cortex were prepared as described previously (Friberg et a!., 1998; Sims, 1990 
Statistical analysis
One factor analysis of variance followed by Scheffe's test was used to compare physiologic parameters among groups.
The infarct size in treated and untreated groups were compared using Kruskal-Wallis test followed by Mann-Whitney U-test.
RESULTS
Blood gases (mm Hg ± SD) at 3 minutes after occlu sion were Pao2 117 ± 16, Paco2 37 ± 4, and pH 7.42 ± 0.03, and blood glucose levels (mmol/L ± SD) were 5.2 ± 0.8 in the vehicle-treated rats with no significant dif ferences among groups (data not shown). Blood pressure (mm Hg ± SD) was 108 ± 12 in the vehicle-treated group with no significant differences among groups (data not shown). Rectal temperature was monitored before, dur ing, and after ischemia until 48 hours. There was no significant temperature effect by CsA or MeValCsA at any time point (data not shown). Figure 1 shows the calculated infarct size. The mean cortical infarct size was 25% in the vehicle-treated ani mals and 11% in both the CsA-and the MeVaICsA treated groups. The decrease in cortical infarct size in both treated groups was highly significant. In the stria tum, the infarct in vehicle-treated animals was 9%, whereas in the CsA-and MeValCsA-treated animals, it decreased to 2% and 3%, respectively. The decrease in striatal damage in the treated animals was also highly significant. The mean volume (mm 3 ± SD) of the con tralateral hemisphere was 953 ± 37 (n = 21), and there were no statistically significant differences among groups (data not shown). 
DISCUSSION
The results in the present study clearly show that post ischemic treatment with either CsA or with its nonim munosuppressive analogue MeValCsA ameliorates neu ronal damage after transient focal ischemia in the rat.
Because the immunosuppressive action of CsA does not seem to add further protection as compared to that by its nonimmunosuppressive analogue MeValCsA, and be- 
Mitochondrial permeability transition
Mitochondria are the main source of A TP in cells and play a central role in cellular calcium homeostasis (Gunter and Gunter, 1994) . If cytosolic calcium concen trations become too high, as following excessive neuro nal firing or severe energy shortage, the subsequent mi tochondrial calcium overload will initiate the opening of a nonspecific pore in the inner membrane, the MPT pore (Zoratti and Szabo, 1995) . This calcium-dependent for mation of the MPT pore represents an abrupt increase of permeability to solutes normally impermeable to the in ner membrane (MW <1500 Da), causing osmotic swell ing and rupture of the outer membrane, with concomitant loss of mitochondrial proteins (Liu et aI., 1996; Susin et aI., 1999) . First characterized in isolated mitochondria (Hunter and Haworth, 1979a) , the phenomenon has now been described in vitro (Kristal and Dubinsky, 1997) and recent studies show that MPT may be of crucial impor tance in the development of cell damage in vivo (Friberg et aI., 1998) . The MPT pore acts as a tightly regulated inner membrane channel, but its composition is yet not defined. Widely accepted components are the adenine nucleotide translocase of the inner membrane and matrix specific cyclophilin D (Halestrap et aI., 1998) , whereas porin of the outer mitochondrial membrane, creatine ki nase and Bax may modulate its activity (Beutner et aI., 1998; Marzo et aI., 1998) . Cyclosporin A inhibits open ing of the MPT pore through binding to cyclophilin D, thereby preventing its translocation to the inner mito chondrial membrane (Connern and Halestrap, 1994) and
Me ValCsA prevents translocation of cyclophilin D equally well in brain mitochondria (Friberg et aI., 1999) .
This makes the MPT pore less sensitive to induction by calcium ions. 1. (A) Cortical infarct size and (8) striatal infarct size in rats exposed to 2 hours of middle cerebral artery occlusion followed by 48 hours of reperfusion. The rats were treated with vehicle (Vh), cyclosporin A (CsA) or N-methyl-Val-4-cyclosporin A (MeVaICsA) as a bolus injection intra peritoneally, 10 mg/kg immediately at reperfusion and at 24 hours of reper fusion. The infarct size in the cortex and the striatum was assessed as the percentage of the total volume of the contralateral hemisphere. The mean volume (mm3 ± SO) of the contralateral hemisphere was 953 ± 37 (n = 21), and there were no statistically significant differences among groups (data not shown). The infarct size in treated and untreated groups were compared using Kruskal-Wallis test followed by Mann-Whitney U-test. 
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Ischemia-reperfusion damage and the mitochondrial permeability transition
When blood supply to the brain is blocked because of occlusion of the proximal MCA as in stroke, an infarc tion develops in the central core (Garcia, 1992) , encom passing caudoputamen and the overlaying cortex. The perifocal area surrounding the infarct, the penumbra, is potentially salvageable but will eventually lose viability unless successful intervention is initiated. Recently, caspase inhibitors have been shown to ameliorate stroke damage by 40% to 50% in a mouse model of transient focal ischemia (Namura et aI., 1998) , supporting the in volvement of caspase-mediated cell death, in stroke damaged neurons. Further support for caspase-mediated cell death in stroke comes from the recent demonstration that cytochrome c is released in the ischemic brain after transient MCAO in the rat (Fujimura et aI., 1998) . Mi tochondrial cytochrome c release precedes caspase acti vation and cell death in many cell types and may be effectuated through several pathways (Cai et aI., 1998) , but, because cytochrome c resides in the intermembrane space, an increased permeability of the outer membrane is necessary. Osmotic swelling caused by opening of the MPT pore leads to rupture of the outer membrane and cytochrome c release, but release may also be seen with out a preceding loss of mitochondrial potential and swelling in some in vitro systems (Kluck et aI., 1997; Yang et aI., 1997) . This has been explained by the for mation of Bax-regulated channels in the outer membrane (Eskes et aI., 1998) , which also, by unknown mecha nisms, may be regulated by CsA (Jiirgensmeier et aI., 1998). In the rat brain, CsA sensitive mitochondrial swelling has been shown to occur in vivo (Friberg et aI., 1998) and in this study we show that treatment with blockers of MPT significantly ameliorates neuronal dam age in stroke.
Cyclosporin A and MeValCsA
An anti-ischemic effect of CsA in a model of transient MCAO has been demonstrated (Shiga et aI., 1992) , in B which the animals were administered an oral dose for a week before the insult to suppress the immune system and to reduce edema formation. In a more recent study (Butcher et aI., 1997) , CsA was protective when admin istered after endothelin induced focal ischemia. The ef fect was similar to that of FK 506, an immunosuppres sant but not a blocker of MPT (Butcher et aI., 1997) .
Furthermore, CsA has been shown to protect neurons in a model of global ischemia (Uchino et aI., 1998) and in a model of insulin-induced hypoglycemic coma (Friberg et aI., 1998) . The novel part of this study is that not only CsA protects from ischemic damage, but that the non immunosuppressive analogue MeValCsA protects equally well. MeValCsA has been shown to prevent loss of mitochondrial potential and induction of apoptosis in a ce\l free system (Zamzami et aI., 1996) and more re cently to protect PC 12 cells from metabolic inhibition (Seaton et aI., 1998) . In this study we show for the first time that MeValCsA is neuroprotective in vivo. Because MeValCsA exerts its main effect through inhibition of MPT in a concentration-dependent manner, similar to CsA (Liu et aI., 1992) and not through inhibition of calcineurin-mediated events and immunosuppression, we conclude that the preservation of mitochondrial integrity and function through blockade of the MPT is of crucial importance in the reperfusion phase after ischemia.
Hence, there is increasing evidence that the mitochon drion is a point of convergence for death stimuli and may initiate cell death pathways through the activation of MPT (Halestrap et aI., 1998; Kroemer et aI., 1998; Le masters et aI., 1998) . This can be envisaged to take place through the activation of processes typically occurring in apoptosis as well as during processes leading to necrosis.
In the former case, transient activation of MPT leads to the release of mitochondrial proteins and a subsequent activation of caspases followed by DNA fragmentation and cell death. Alternatively, after a period of severe cellular energy shortage, large-scale irreversible MPT may be activated at reperfusion. The subsequent uncou-pIing of the electron transport chain, profound A TP de crease, and loss of free radical scavengers may lead to a surge of calcium-activated cellular degradation and free radical damage causing cell death. Both these cell death processes are blocked if MPT is inhibited by CsA and MeValCsA.
